|Keith A. Markey, Ph.D., M.B.A.||
Griffin Securities, Inc.
|Raghuram Selvaraju, Ph.D.||
H.C. Wainwright & Co.
|John D. Vandermosten, CFA||
RXi Pharmaceuticals is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding RXi Pharmaceuticals's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of RXi Pharmaceuticals or its management. RXi Pharmaceuticals does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.